Atria Wealth Solutions’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$400K Sell
1,524
-248
-14% -$60.4K 0.01% 1026
2025
Q1
$412K Sell
1,772
-9
-0.5% -$2.18K 0.01% 1291
2024
Q4
$408K Sell
1,781
-67
-4% -$15.4K ﹤0.01% 1378
2024
Q3
$413K Sell
1,848
-28
-1% -$6.15K ﹤0.01% 1337
2024
Q2
$382K Buy
1,876
+60
+3% +$12.2K ﹤0.01% 1365
2024
Q1
$397K Sell
1,816
-153
-8% -$33.7K ﹤0.01% 1370
2023
Q4
$448K Buy
1,969
+53
+3% +$11.1K 0.01% 1276
2023
Q3
$385K Sell
1,916
-227
-11% -$47.9K 0.01% 1266
2023
Q2
$444K Sell
2,143
-36
-2% -$6.98K 0.01% 1216
2023
Q1
$429K Buy
2,179
+598
+38% +$123K 0.01% 1210
2022
Q4
$320K Buy
1,581
+197
+14% +$38.5K 0.01% 1321
2022
Q3
$244K Buy
1,384
+7
+0.5% +$1.43K ﹤0.01% 1437
2022
Q2
$277K Buy
1,377
+22
+2% +$4.69K 0.01% 1254
2022
Q1
$307K Buy
+1,355
New +$319K 0.01% 1309

Other funds holding LH

Atria Wealth Solutions's LH Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Labcorp (LH) stake by 14% in Q2 2025, selling an estimated $60.4K and leaving 1,524 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #1026.

Atria Wealth Solutions first reported a position in LH in Q1 2022 and has held it in 14 quarters since. The position peaked at $448K in Q4 2023. 974 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • Atria Wealth Solutions held 1,524 shares of Labcorp worth $400K as of Q2 2025.
  • Atria Wealth Solutions sold 248 Labcorp shares in Q2 2025, an estimated $60.4K.
  • Labcorp made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1026 holding.
  • Atria Wealth Solutions first reported a position in Labcorp in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Labcorp position peaked at $448K in Q4 2023.
  • 974 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.